Julie Steenhuysen – Page 9

Labs reject dramatic findings on cancer drug in Alzheimer’s mice

May 13, 2019 at 11:46 p.m.

CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was...

Pfizer takes its shot at a vaccine for evasive superbug

May 13, 2019 at 11:46 p.m.

CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped...

Moore shows that as cities grow, tornado damage grows with them

August 24, 2021 at 10:09 a.m.

(Reuters) - Moore, Oklahoma, has had the bad luck of being hit by two highly destructive tornadoes, both in the month of May, 14 years apart. But the Moore that...

Bristol melanoma drug combo marks new advance in immunotherapy

August 24, 2021 at 9:42 a.m.

CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness...

Bristol melanoma drug combo marks new advance in immunotherapy

May 13, 2019 at 11:43 p.m.

CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness...

Many in U.S. don’t get proper testing for hepatitis C: CDC

August 24, 2021 at 9:22 a.m.

NEW YORK (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials...

Baxter’s Alzheimer’s disease drug fails in late-stage trial

August 24, 2021 at 9:18 a.m.

NEW YORK (Reuters) - In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed...

Many in U.S. don’t get proper testing for hepatitis C: CDC

May 13, 2019 at 11:42 p.m.

NEW YORK (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, U.S. health officials...

Baxter’s Alzheimer’s disease drug fails in late-stage trial

May 13, 2019 at 11:41 p.m.

NEW YORK (Reuters) - In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed...

Key trial of Seaside autism drug fails to show benefit

August 24, 2021 at 8:56 a.m.

CHICAGO (Reuters) - The first-ever drug designed to treat social impairments associated with autism failed to show a benefit in a midstage trial, representing a blow to families and to...

All Stories